[212Pb]Pb-PSC-PEG-T

N/A

Report date: 2025/11/20 16:04:20

NME

Base Information

Drug Name[212Pb]Pb-PSC-PEG-T

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Lead > 212PbRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor 2 binders

TargetsSomatostatin receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesViewpoint Molecular Targeting Inc

China Registration ClassN/A

Develop Information

Active CompaniesViewpoint Molecular Targeting Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A